Hypertension in Pregnancy

Advances in Chronic Kidney Disease

Volumn 14, Issue 2, 2007, Pages 178-190

  Podymow, Tiina ^a   August, Phyllis ^b  

^a MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

antihypertensive; blood pressure; Hypertension; preeclampsia; pregnancy

Indexed keywords

ACETYLSALICYLIC ACID; ALPHA TOCOPHEROL; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIOXIDANT; ASCORBIC ACID; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDRALAZINE; HYDROCHLOROTHIAZIDE; LABETALOL; MAGNESIUM; METHYLDOPA; NIFEDIPINE; NITROPRUSSIDE SODIUM; VASODILATOR AGENT;

ARTICLE; BORDERLINE HYPERTENSION; BRADYCARDIA; CARDIOVASCULAR RISK; CONTINUOUS INFUSION; CYANIDE POISONING; ELECTROLYTE DISTURBANCE; FEMALE; FETUS GROWTH; FETUS RISK; HEART ARRHYTHMIA; HELLP SYNDROME; HUMAN; HYPERTENSION; HYPOVOLEMIA; INTRAUTERINE GROWTH RETARDATION; LOADING DRUG DOSE; LOW DRUG DOSE; MATERNAL HYPERTENSION; PATHOPHYSIOLOGY; PATIENT COUNSELING; PLACENTA CIRCULATION; PREECLAMPSIA; PREGNANCY; PRIORITY JOURNAL; RECOMMENDED DRUG DOSE; RISK BENEFIT ANALYSIS; SIDE EFFECT; SLOW RELEASE FORMULATION; TACHYCARDIA; THROMBOCYTOPENIA;

ALGORITHMS; ANTIHYPERTENSIVE AGENTS; CHRONIC DISEASE; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; HYPERTENSION; HYPERTENSION, PREGNANCY-INDUCED; POSTPARTUM PERIOD; PRECONCEPTION CARE; PREGNANCY; PREGNANCY OUTCOME; RISK;

EID: 33947543279     PISSN: 15485595     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.ackd.2007.01.008     Document Type: Article

References (38)

1. Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy. Am J Obstet Gynecol 183 (2000) S1-S22
2. Samadi A.R., Mayberry R.M., Zaidi A.A., et al. Maternal hypertension and associated pregnancy complications among African-American and other women in the United States. Obstet Gynecol 87 (1996) 557-563
3. Sibai B.M. Diagnosis, controversies, and management of the syndrome of hemolysis, elevated liver enzymes, and low platelet count. Obstet Gynecol 103 (2004) 981-991
4. Bellomo G., Narducci P.L., Rondoni F., et al. Prognostic value of 24-hour blood pressure in pregnancy. JAMA 282 (1999) 1447-1452
5. Schenker J.G., and Chowers I. Pheochromocytoma and pregnancy: Review of 89 cases. Obstet Gynecol Surv 26 (1971) 739-747
6. Rey E., and Couturier A. The prognosis of pregnancy in women with chronic hypertension. Am J Obstet Gynecol 171 (1994) 410-416
7. Dunlop J.C. Chronic hypertension and perinatal mortality. Proc R Soc Med 59 (1966) 838-841
8. Chang J., Elam-Evans L.D., Berg C.J., et al. Pregnancy-related mortality surveillance-United States, 1991-1999. MMWR Surveill Summ 52 (2003) 1-8
9. Jones D.C., and Hayslett J.P. Outcome of pregnancy in women with moderate or severe renal insufficiency. N Engl J Med 335 (1996) 226-232
10. Brown M.A., and Buddle M.L. Hypertension in pregnancy: Maternal and fetal outcomes according to laboratory and clinical features. Med J Aust 165 (1996) 360-365
11. Mabie WC, Pernoll ML, Biswas MK: Chronic hypertension in pregnancy. Obstet Gynecol 167:197-205, 986
12. Cooper W.O., Hernandez-Diaz S., Arbogast P.G., et al. Major congenital malformations after first-trimester exposure to ACE inhibitors. N Engl J Med 354 (2006) 2443-2451
13. Podymow T., and August P. Pregnancy and gender issues in the renal transplant recipient. In: Weir M. (Ed). Medical Management of Kidney Transplantation (2005), Lippincott Williams & Wilkins, Philadelphia, PA 238-243
14. Higgins J.R., Walshe J.J., Conroy R.M., et al. The relation between maternal work, ambulatory blood pressure, and pregnancy hypertension. J Epidemiol Community Health 56 (2002) 389-393
15. Villar J., Abdel-Aleem H., Merialdi M., et al. World Health Organization randomized trial of calcium supplementation among low calcium intake pregnant women. Am J Obstet Gynecol 194 (2006) 639-649
16. Abalos E., Duley L., Steyn D.W., et al. Antihypertensive drug therapy for mild to moderate hypertension during pregnancy. Cochrane Database Syst Rev (2001) CD002252
17. Magee L.A., Ornstein M.P., and von Dadelszen P. Fortnightly review: Management of hypertension in pregnancy. BMJ 318 (1999) 1332-1336
18. Helewa M.E., Burrows R.F., Smith J., et al. Report of the Canadian Hypertension Society Consensus Conference: 1. Definitions, evaluation and classification of hypertensive disorders in pregnancy. CMAJ 157 (1997) 715-725
19. Brown M.A., Hague W.M., Higgins J., et al. The detection, investigation and management of hypertension in pregnancy: Full consensus statement. Aust N Z J Obstet Gynaecol 40 (2000) 139-155
20. Magee L.A. Drugs in pregnancy. Antihypertensives. Best Pract Res Clin Obstet Gynaecol 15 (2001) 827-845
21. Umans J.G. Medications during pregnancy: Antihypertensives and immunosuppressives. Adv Chronic Kid Dis 14 (2007) 191-205
22. Duley L., Henderson-Smart D.J., Knight M., et al. Antiplatelet agents for preventing pre-eclampsia and its complications. Cochrane Database Syst Rev (2004) CD004659
23. Rumbold A.R., Crowther C.A., Haslam R.R., Dekker G.A., and Robinson J.S. Vitamins C and E and the risks of preeclampsia and perinatal complications. N Engl J Med 354 (2006) 1796-1806
24. Levine R.J., Thadhani R., Qian C., et al. Urinary placental growth factor and risk of preeclampsia. JAMA 293 (2005) 77-85
25. Visser W., and Wallenburg H.C. Central hemodynamic observations in untreated preeclamptic patients. Hypertension 17 (1991) 1072-1077
26. Ayala D.E., Hermida R.C., Mojon A., et al. Circadian blood pressure variability in healthy and complicated pregnancies. Hypertension 30 (1997) 603-610
27. Venuto T., and Lindheimer M. Animal models. In: Lindheimer M., Roberts J., and Cunningham F. (Eds). Chesley's Hypertensive Disorders in Pregnancy (1999), Appleton & Lange, Stamford, CA 487-517
28. Groenendijk R., Trimbos J.B., and Wallenburg H.C. Hemodynamic measurements in preeclampsia: Preliminary observations. Am J Obstet Gynecol 150 (1984) 232-236
29. Lang R.M., Pridjian G., Feldman T., et al. Left ventricular mechanics in preeclampsia. Am Heart J 121 (1991) 1768-1775
30. Katz V.L., Farmer R., and Kuller J.A. Preeclampsia into eclampsia: Toward a new paradigm. Am J Obstet Gynecol 182 (2000) 1389-1396
31. Hinchey J., Chaves C., Appignani B., et al. A reversible posterior leukoencephalopathy syndrome. N Engl J Med 334 (1996) 494-500
32. Sibai B.M., Mercer B.M., Schiff E., et al. Aggressive versus expectant management of severe preeclampsia at 28 to 32 weeks' gestation: A randomized controlled trial. Am J Obstet Gynecol 171 (1994) 818-822
33. Chames M.C., Haddad B., Barton J.R., et al. Subsequent pregnancy outcome in women with a history of HELLP syndrome at < or = 28 weeks of gestation. Am J Obstet Gynecol 188 (2003) 1504-1507
34. Sibai B.M., Mercer B., and Sarinoglu C. Severe preeclampsia in the second trimester: Recurrence risk and long-term prognosis. Am J Obstet Gynecol 165 (1991) 1408-1412
35. Chesley L. Hypertensive Disorders in Pregnancy (1978), Appleton-Century-Crofts, New York, NY
36. Wilson B.J., Watson M.S., Prescott G.J., et al. Hypertensive diseases of pregnancy and risk of hypertension and stroke in later life: Results from cohort study. BMJ 326 (2003) 845
37. Haukkamaa L., Salminen M., Laivuori H., et al. Risk for subsequent coronary artery disease after preeclampsia. Am J Cardiol 93 (2004) 805-808
38. Beardmore K.S., Morris J.M., and Gallery E.D. Excretion of antihypertensive medication into human breast milk: A systematic review. Hypertens Pregnancy 21 (2002) 85-95